Victory Capital Management
IPSC icon

Victory Capital Management’s Century Therapeutics IPSC Stock Holding History

Victory Capital Management’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.5K Buy
+14,101
New +$32.2K ﹤0.01% 2415

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Victory Capital Management's IPSC Position: Q2 2026 in Review

Victory Capital Management opened a new position in Century Therapeutics (IPSC) in Q2 2026: 14,101 shares worth $34.5K. The stake represents ﹤0.01% of the portfolio and ranks #2415 among its holdings.

100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Victory Capital Management held 14,101 shares of Century Therapeutics worth $34.5K as of Q2 2026.
  • Century Therapeutics was a new Victory Capital Management position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2415 holding.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.